AOP Orphan is the European pioneer in Orphan Diseases unconditionally committed to bringing not only drugs but full treatment support to patients with rare diseases.

As a company, we are small enough to be really close to our patients, yet we are large enough to be able to provide them high-quality, personalized customer care.

AOP having international expertise in pharmaceutical and clinical development as well as distribution and marketing of drugs in the rare disease area offers flexible solutions for in- and out-licensing partnerships.

We set great store by research – even though AOP Orphan is not a large company. Top priority here is on securing the support and experience of patients.

To provide patients with effective drugs COLLABORATION is the key for success- within and between pharmaceutical industry and academia.

Our employees’ expertise and commitment is key for what we do for our patients. We invite people who thrive in an entrepreneurial and dynamic working environment. Join us and develop your career at AOP!

One of the qualities of AOP I have learnt to appreciate is that AOP treats people as people with rare diseases; and not as an entry point to new markets.

Striving to help neglected patients is a privilege, but also a huge responsibility. In today’s complex world it is essential that we create a climate of trust, provide our teams with clarity and inspire them for excellence.

We don’t just talk about personalised medicine – we live and breathe it

Imagine you find a solution to a complex rare disease and can make this available to afflicted people.

What drives me are the highly individual needs of patients and physicians. We try to predict these, understand them and, as a consequence, act in a rapid, professional and empathic way.

Finding solutions for apparently impossible tasks, always focusing on the patients with a deep appreciation of their disease experience makes AOP Orphan a unique partner.